Non-covalent loading of anti-cancer doxorubicin by modularizable peptide self-assemblies for a nanoscale drug carrier

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

We prepared nanoscale, modularizable, self-assembled peptide nanoarchitectures with diameters less of than 20 nm by combining β-sheet-forming peptides tethering a cell-penetrating peptide or a nuclear localization signal sequence. We also found that doxorubicin (Dox), an anti-cancer drug, was non-covalently accommodated by the assemblies at a ratio of one Dox molecule per ten peptides. The Dox-loaded peptide assemblies facilitated cellular uptake and subsequent nuclear localization in HeLa cells, and induced cell death even at low Dox concentrations. This peptide nanocarrier motif is a promising platform for a biocompatible drug delivery system by altering the targeting head groups of the carrier peptides.

Cite

CITATION STYLE

APA

Tomizaki, K. ya, Kishioka, K., Kataoka, S., Miyatani, M., Ikeda, T., Komada, M., … Usui, K. (2017). Non-covalent loading of anti-cancer doxorubicin by modularizable peptide self-assemblies for a nanoscale drug carrier. Molecules, 22(11). https://doi.org/10.3390/molecules22111916

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free